Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Article

J App Pharm Sci. 2014; 4(8): 056-058


Chronic LD50 Vs. Safest Dose for the Methanolic Extract of Curry Leaves (Murraya koenigii) Cultivated in Malaysia

Marwan Saad Azzubaidi, Anil Kumar Saxena, Ahmed Ghazi Alattraqchi, Abdualrahman Mohammed Abdualkader.

Abstract
Curry leaf viz. Murraya koenigii leaves (MKL) is an ancient Ayurvedic medicinal plant that has recently been described as possessing robust anti-inflammatory and antioxidant activities. The current study was conducted to determine the long-term LD50 of the methanolic extract of MKL during daily oral administration. Five groups of Sprague Dawley rats were recruited into the study. Each group comprised six rats including the control group (1). The oral MKL doses used for groups (2) to (5) were 50, 100, 200 and 400 mg/kg/day, respectively for a duration of ten weeks. The daily measured toxicity parameters were food and water consumption, body weight, general activity in forced swimming test and the cumulative mortalities. Group (5) showed 100% mortality within the first month of the study. Group (4) showed 50% mortality with signs of toxicity for the other 3 animals. Group (3) showed no mortalities but signs of toxicity for one animal were observed. No mortalities or toxicity signs were observed for any of group (2) animals. It can be concluded that the chronic LD50 for Malaysian cultivated MKL is 200 mg/kg/day, and the safest dose of MKL methanolic extract that can be implemented for long-term studies should not exceed 50 mg/kg/day.

Key words: Chronic toxicity, LD50, Murraya koenigii, rats



Share this Article


Advertisement
Journal of Environmental and Occupational Science

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.